Sort
10,766 grants matching “checkpoint inhibitor”
Project 4: Therapeutic Targeting of Replication Stress Vulnerabilities in Small Cell Lung Cancer
$463,389Lauren Averett Byers · Ut Southwestern Medical Center · P50 · FY2021 · CA
Mechanisms of cell death in cutaneous melanoma
$463,189Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$463,156Chuan-Yuan Li · Duke University · R01 · FY2018 · CA
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer
$463,085Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2020 · CA
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer
$462,998Terence Marques Williams · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$462,960Willy Hugo · University Of California Los Angeles · R01 · FY2022 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$462,960Willy Hugo · University Of California Los Angeles · R01 · FY2021 · CA
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
$462,812Li Liu · Ut Southwestern Medical Center · R01 · FY2024 · CA
Decoding tobacco-related oral cancer ecosystem by integrative approach
$462,811Aik Choon Tan · University Of Utah · R01 · FY2022 · DE
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer
$462,785David H Sherr · Boston University Medical Campus · R01 · FY2022 · ES
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$462,773Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$462,770Lily Yang · Emory University · R01 · FY2023 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$462,770Lily Yang · Emory University · R01 · FY2022 · CA
Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
$462,426J. Silvio Gutkind · University Of California, San Diego · R01 · FY2022 · DE
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
$462,413Simon N Powell · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions
$462,410George Georgiou Georgiou · University Of Texas At Austin · U01 · FY2021 · AI
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$462,269Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Targeting Posttranslational Modifications in Breast Carcinogenesis
$462,243Yong Wan · Emory University · R01 · FY2022 · CA
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer
$462,092Sally E Dickinson · University Of Arizona · UG3 · FY2025 · CA
HSP70 and melanoma
$462,002Maureen E Murphy · Wistar Institute · R01 · FY2015 · CA
A New Mode of Inhibition to Target Protein-Protein Interactions by Ligand-Transferred Oxidation
$462,000Juan Pablo Maianti · Albert Einstein College Of Medicine · R35 · FY2025 · GM
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions
$461,998George Georgiou Georgiou · University Of Texas At Austin · U01 · FY2022 · AI
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
$461,996Abraham Ari Hakimi · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
DNA damage response and cancer immunity
$461,897Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
DNA damage response and cancer immunity
$461,897Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA